Clinical Trials Arena on MSN

Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management

Axsome Therapeutics has initiated the FORWARD Phase III trial evaluating AXS-14 for the management of fibromyalgia, with the ...

New Randomized Trial Shows Promising Cognitive Gains in Long COVID Brain Fog Using Home-Based Light Therapy

Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial. The ...
Medscape

D-Mannose Fails to Prevent Urinary Tract Infections in Women

D-Mannose is often recommended for the prevention of urinary tract infections. The results of a randomized, double-blind study from the United Kingdom now cast doubt on the effectiveness of the simple ...
Lupus Foundation of America

New Research Explores Efficacy of Belimumab and Rituximab Combination Therapy for Systemic Lupus Erythematosus

In a new phase 3, double-blind study, researchers explored the efficacy and safety of combination therapy using subcutaneous (SC) belimumab and rituximab for the treatment of active systemic lupus ...

Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes

The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate ...
BMJ

Topical glyceryl trinitrate (GTN) and eccentric exercises in the treatment of mid-portion achilles tendinopathy (the NEAT trial): a randomised double-blind placebo-controlled trial

Objectives To investigate if daily treatment with glyceryl trinitrate (GTN) ointment, over 24 weeks combined with a 12-week eccentric exercise programme is more effective for chronic mid-portion ...